
Opinion|Videos|April 28, 2025
Clinical Benefits of BPH Treatments
Author(s)Christopher E. Kelly, MD
Panelist discusses how clinical data from multiple studies demonstrate that aqua ablation therapy offers efficacy comparable with that of transurethral resection of the prostate (TURP) while providing superior safety, functionality, and durability benefits.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Aqua Ablation Therapy Benefits
Efficacy:
- Aqua ablation demonstrates noninferior, equal, or superior results compared with TURP (gold standard).
- Measured by International Prostate Symptom Score and Qmax (flow rate).
- 5-year data confirm strong symptom improvement comparable with TURP.
Safety:
- Urinary incontinence:0.1% (aqua ablation) vs up to 7%+ (TURP)
- Blood transfusion rate:0.1% (aqua ablation), lower than TURP
- Ejaculation preservation:89%-90% (aqua ablation) vs ~75% (TURP)
- Erectile dysfunction rate:0% for aqua ablation
Durability:
- Retreatment rate (5 years):
- TURP: ~12%
- Aqua ablation: ~6% (half of TURP’s rate)
Aqua ablation provides a safer, more durable alternative to TURP with comparable or superior efficacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Urocross shows sustained benefit through 24 months post-removal
4
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
5













